Covid-19 Impact on Biobanking Services Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Biobanking Services, including the following market information:
Major competitors identified in this market include Qiagen N.V. (Germany), Hamilton Company (US), Brooks Automation (US), TTP Labtech Ltd (U.K.), VWR Corporation (US), Promega Corporation (US), etc.
Based on the Region:
- Global Biobanking Services Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Biobanking Services Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Biobanking Services Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Biobanking Services Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Qiagen N.V. (Germany), Hamilton Company (US), Brooks Automation (US), TTP Labtech Ltd (U.K.), VWR Corporation (US), Promega Corporation (US), etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Blood Products
- Human Tissues
- Cell Lines
- Nucleic Acids
- Regenerative Medicine
- Life Science
- Clinical Research
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Biobanking Services Industry
1.7 COVID-19 Impact: Biobanking Services Market Trends
2 GLOBAL BIOBANKING SERVICES QUARTERLY MARKET SIZE ANALYSIS
2.1 Biobanking Services Business Impact Assessment - COVID-19
2.1.1 Global Biobanking Services Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Biobanking Services Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Biobanking Services Quarterly Market Size, 2019 VS 2020
3.2 By Players, Biobanking Services Headquarters and Area Served
3.3 Date of Key Players Enter into Biobanking Services Market
3.4 Key Players Biobanking Services Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON BIOBANKING SERVICES SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Blood Products
1.4.2 Human Tissues
1.4.3 Cell Lines
1.4.4 Nucleic Acids
4.2 By Type, Global Biobanking Services Market Size, 2019-2021
5 IMPACT OF COVID-19 ON BIOBANKING SERVICES SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Regenerative Medicine
5.5.2 Life Science
5.5.3 Clinical Research
5.2 By Application, Global Biobanking Services Market Size, 2019-2021
5.2.1 By Application, Global Biobanking Services Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Qiagen N.V. (Germany)
7.1.1 Qiagen N.V. (Germany) Business Overview
7.1.2 Qiagen N.V. (Germany) Biobanking Services Quarterly Revenue, 2020
7.1.3 Qiagen N.V. (Germany) Biobanking Services Product Introduction
7.1.4 Qiagen N.V. (Germany) Response to COVID-19 and Related Developments
7.2 Hamilton Company (US)
7.2.1 Hamilton Company (US) Business Overview
7.2.2 Hamilton Company (US) Biobanking Services Quarterly Revenue, 2020
7.2.3 Hamilton Company (US) Biobanking Services Product Introduction
7.2.4 Hamilton Company (US) Response to COVID-19 and Related Developments
7.3 Brooks Automation (US)
7.3.1 Brooks Automation (US) Business Overview
7.3.2 Brooks Automation (US) Biobanking Services Quarterly Revenue, 2020
7.3.3 Brooks Automation (US) Biobanking Services Product Introduction
7.3.4 Brooks Automation (US) Response to COVID-19 and Related Developments
7.4 TTP Labtech Ltd (U.K.)
7.4.1 TTP Labtech Ltd (U.K.) Business Overview
7.4.2 TTP Labtech Ltd (U.K.) Biobanking Services Quarterly Revenue, 2020
7.4.3 TTP Labtech Ltd (U.K.) Biobanking Services Product Introduction
7.4.4 TTP Labtech Ltd (U.K.) Response to COVID-19 and Related Developments
7.5 VWR Corporation (US)
7.5.1 VWR Corporation (US) Business Overview
7.5.2 VWR Corporation (US) Biobanking Services Quarterly Revenue, 2020
7.5.3 VWR Corporation (US) Biobanking Services Product Introduction
7.5.4 VWR Corporation (US) Response to COVID-19 and Related Developments
7.6 Promega Corporation (US)
7.6.1 Promega Corporation (US) Business Overview
7.6.2 Promega Corporation (US) Biobanking Services Quarterly Revenue, 2020
7.6.3 Promega Corporation (US) Biobanking Services Product Introduction
7.6.4 Promega Corporation (US) Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Biobanking Services Industry
1.7 COVID-19 Impact: Biobanking Services Market Trends
2 GLOBAL BIOBANKING SERVICES QUARTERLY MARKET SIZE ANALYSIS
2.1 Biobanking Services Business Impact Assessment - COVID-19
2.1.1 Global Biobanking Services Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Biobanking Services Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Biobanking Services Quarterly Market Size, 2019 VS 2020
3.2 By Players, Biobanking Services Headquarters and Area Served
3.3 Date of Key Players Enter into Biobanking Services Market
3.4 Key Players Biobanking Services Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON BIOBANKING SERVICES SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Blood Products
1.4.2 Human Tissues
1.4.3 Cell Lines
1.4.4 Nucleic Acids
4.2 By Type, Global Biobanking Services Market Size, 2019-2021
5 IMPACT OF COVID-19 ON BIOBANKING SERVICES SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Regenerative Medicine
5.5.2 Life Science
5.5.3 Clinical Research
5.2 By Application, Global Biobanking Services Market Size, 2019-2021
5.2.1 By Application, Global Biobanking Services Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Qiagen N.V. (Germany)
7.1.1 Qiagen N.V. (Germany) Business Overview
7.1.2 Qiagen N.V. (Germany) Biobanking Services Quarterly Revenue, 2020
7.1.3 Qiagen N.V. (Germany) Biobanking Services Product Introduction
7.1.4 Qiagen N.V. (Germany) Response to COVID-19 and Related Developments
7.2 Hamilton Company (US)
7.2.1 Hamilton Company (US) Business Overview
7.2.2 Hamilton Company (US) Biobanking Services Quarterly Revenue, 2020
7.2.3 Hamilton Company (US) Biobanking Services Product Introduction
7.2.4 Hamilton Company (US) Response to COVID-19 and Related Developments
7.3 Brooks Automation (US)
7.3.1 Brooks Automation (US) Business Overview
7.3.2 Brooks Automation (US) Biobanking Services Quarterly Revenue, 2020
7.3.3 Brooks Automation (US) Biobanking Services Product Introduction
7.3.4 Brooks Automation (US) Response to COVID-19 and Related Developments
7.4 TTP Labtech Ltd (U.K.)
7.4.1 TTP Labtech Ltd (U.K.) Business Overview
7.4.2 TTP Labtech Ltd (U.K.) Biobanking Services Quarterly Revenue, 2020
7.4.3 TTP Labtech Ltd (U.K.) Biobanking Services Product Introduction
7.4.4 TTP Labtech Ltd (U.K.) Response to COVID-19 and Related Developments
7.5 VWR Corporation (US)
7.5.1 VWR Corporation (US) Business Overview
7.5.2 VWR Corporation (US) Biobanking Services Quarterly Revenue, 2020
7.5.3 VWR Corporation (US) Biobanking Services Product Introduction
7.5.4 VWR Corporation (US) Response to COVID-19 and Related Developments
7.6 Promega Corporation (US)
7.6.1 Promega Corporation (US) Business Overview
7.6.2 Promega Corporation (US) Biobanking Services Quarterly Revenue, 2020
7.6.3 Promega Corporation (US) Biobanking Services Product Introduction
7.6.4 Promega Corporation (US) Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Biobanking Services Assessment
Table 9. COVID-19 Impact: Biobanking Services Market Trends
Table 10. COVID-19 Impact Global Biobanking Services Market Size
Table 11. Global Biobanking Services Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Biobanking Services Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Biobanking Services Market Growth Drivers
Table 14. Global Biobanking Services Market Restraints
Table 15. Global Biobanking Services Market Opportunities
Table 16. Global Biobanking Services Market Challenges
Table 17. By Players, Biobanking Services Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Biobanking Services Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Biobanking Services Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Biobanking Services Market
Table 21. Key Players Biobanking Services Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Biobanking Services Market Size 2019-2021, (US$ Million)
Table 24. Global Biobanking Services Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Biobanking Services Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 57. Qiagen N.V. (Germany) Business Overview
Table 58. Qiagen N.V. (Germany) Biobanking Services Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Qiagen N.V. (Germany) Biobanking Services Product
Table 60. Qiagen N.V. (Germany) Response to COVID-19 and Related Developments
Table 61. Hamilton Company (US) Business Overview
Table 62. Hamilton Company (US) Biobanking Services Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Hamilton Company (US) Biobanking Services Product
Table 64. Hamilton Company (US) Response to COVID-19 and Related Developments
Table 65. Brooks Automation (US) Business Overview
Table 66. Brooks Automation (US) Biobanking Services Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Brooks Automation (US) Biobanking Services Product
Table 68. Brooks Automation (US) Response to COVID-19 and Related Developments
Table 69. TTP Labtech Ltd (U.K.) Business Overview
Table 70. TTP Labtech Ltd (U.K.) Biobanking Services Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. TTP Labtech Ltd (U.K.) Biobanking Services Product
Table 72. TTP Labtech Ltd (U.K.) Response to COVID-19 and Related Developments
Table 73. VWR Corporation (US) Business Overview
Table 74. VWR Corporation (US) Biobanking Services Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. VWR Corporation (US) Biobanking Services Product
Table 76. VWR Corporation (US) Response to COVID-19 and Related Developments
Table 77. Promega Corporation (US) Business Overview
Table 78. Promega Corporation (US) Biobanking Services Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Promega Corporation (US) Biobanking Services Product
Table 80. Promega Corporation (US) Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Biobanking Services Assessment
Table 9. COVID-19 Impact: Biobanking Services Market Trends
Table 10. COVID-19 Impact Global Biobanking Services Market Size
Table 11. Global Biobanking Services Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Biobanking Services Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Biobanking Services Market Growth Drivers
Table 14. Global Biobanking Services Market Restraints
Table 15. Global Biobanking Services Market Opportunities
Table 16. Global Biobanking Services Market Challenges
Table 17. By Players, Biobanking Services Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Biobanking Services Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Biobanking Services Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Biobanking Services Market
Table 21. Key Players Biobanking Services Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Biobanking Services Market Size 2019-2021, (US$ Million)
Table 24. Global Biobanking Services Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Biobanking Services Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Biobanking Services Market Size, 2019-2021 (US$ Million)
Table 57. Qiagen N.V. (Germany) Business Overview
Table 58. Qiagen N.V. (Germany) Biobanking Services Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Qiagen N.V. (Germany) Biobanking Services Product
Table 60. Qiagen N.V. (Germany) Response to COVID-19 and Related Developments
Table 61. Hamilton Company (US) Business Overview
Table 62. Hamilton Company (US) Biobanking Services Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Hamilton Company (US) Biobanking Services Product
Table 64. Hamilton Company (US) Response to COVID-19 and Related Developments
Table 65. Brooks Automation (US) Business Overview
Table 66. Brooks Automation (US) Biobanking Services Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Brooks Automation (US) Biobanking Services Product
Table 68. Brooks Automation (US) Response to COVID-19 and Related Developments
Table 69. TTP Labtech Ltd (U.K.) Business Overview
Table 70. TTP Labtech Ltd (U.K.) Biobanking Services Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. TTP Labtech Ltd (U.K.) Biobanking Services Product
Table 72. TTP Labtech Ltd (U.K.) Response to COVID-19 and Related Developments
Table 73. VWR Corporation (US) Business Overview
Table 74. VWR Corporation (US) Biobanking Services Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. VWR Corporation (US) Biobanking Services Product
Table 76. VWR Corporation (US) Response to COVID-19 and Related Developments
Table 77. Promega Corporation (US) Business Overview
Table 78. Promega Corporation (US) Biobanking Services Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Promega Corporation (US) Biobanking Services Product
Table 80. Promega Corporation (US) Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Biobanking Services Product Picture
Figure 2. Biobanking Services Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Biobanking Services Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Biobanking Services Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Biobanking Services Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Biobanking Services Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Biobanking Services Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Biobanking Services Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Biobanking Services Market Size Market Share, 2019-2021
Figure 1. Biobanking Services Product Picture
Figure 2. Biobanking Services Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Biobanking Services Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Biobanking Services Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Biobanking Services Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Biobanking Services Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Biobanking Services Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Biobanking Services Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Biobanking Services Market Size Market Share, 2019-2021
